Medetomidine Withdrawal Webinar - November 9, 2026
Includes a Live Web Event on 11/09/2026 at 3:00 PM (EST)
-
Register
- Non-Member - Free!
- Regular Member - Free!
- Retired - Free!
- Early Career Physician - Free!
- Resident - Free!
- Student - Free!
- Associate - Free!
- ASAM Staff - Free!
- International Member - Free!
- Emeritus Member - Free!
- Provisional Member - Free!
- Fellow Member - Free!
- Honorary Member - Free!
- CRT Member - Free!
Medetomidine Withdrawal Webinar
Monday, November 9th, 2026 | 3:00 pm - 4:00 pm EST
Live Webinar
Overview
This 60-minute webinar provides clinical guidance on the recognition and management of medetomidine intoxication and withdrawal, an emerging issue driven by the increasing presence of medetomidine in the unregulated opioid supply. It describes how medetomidine exposure can cause severe, potentially life-threatening withdrawal symptoms that differ from traditional opioid withdrawal and may require new treatment approaches. Learners will be able to identify and manage a newly emerging and serious withdrawal syndrome in a rapidly changing drug supply environment.
The target audience for this webinar is physicians, nurses, NPs, PAs, pharmacists, social workers, and researchers who work with patients.
Learning Objectives
- Describe the emergence of medetomidine in the unregulated drug supply and distinguish the clinical features of medetomidine-opioid toxicity from opioid toxicity alone, including implications for acute assessment, monitoring, and management.
- Recognize the presentation of medetomidine withdrawal and differentiate it from opioid withdrawal and other medical or psychiatric conditions that may present with similar signs and symptoms.
- Evaluate the current evidence informing the treatment of medetomidine-related toxicity and withdrawal, identify practical management strategies used in clinical settings, and discuss priority areas for future research to address existing knowledge gaps.
Registration Rates
| ASAM Learner Type | Rate |
| ASAM Member | $0 |
| Non-Member | $0 |
| Associate Member | $0 |
| Resident Member* | $0 |
| Student Member* | $0 |
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to [email protected] within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 11/09/2026
Close Access Date: 11/09/2029
Instructions
- Click on the Contents tab to begin this activity.
- Attend the Virtual Live Webinar - Monday, November 9th, 2026, 3:00 pm Eastern Time.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click Complete Presenter Evaluation to provide valuable feedback about presenters. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Certificate of Completion in the box titled Certificate of Completion. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail [email protected]
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Bridget Durkin, MD, MBE
Assistant Professor of Clinical Medicine
Hospital of the University of Pennsylvania
Bridget R. Durkin, MD, MBE is trained in addiction medicine and bioethics, and is an Assistant Professor of Clinical Medicine in Palliative Care at the Hospital of the University of Pennsylvania in Philadelphia, PA.
There, she serves on the Opioid Use Disorder Workgroup of the Penn Medicine Opioid Task Force. She is also a member of the multidisciplinary hospital Ethics Committee. She completed a fellowship in Addiction Medicine at Cooper University Hospital in Camden, New Jersey. She trained in Internal Medicine and Palliative Care at the Hospital of the University of Pennsylvania, where she also obtained a master’s degree in Bioethics. Her interests include interdisciplinary medical education on clinical ethics, substance use disorders, and palliative care. She is passionate about supporting vulnerable patients, especially those living with substance use disorders and comorbid serious illness.
No Relevant Financial Disclosures
Michael J. Lynch
MD
Dr. Michael Lynch is an assistant professor of Emergency Medicine and Pediatrics at the University of Pittsburgh. He is board certified in Emergency Medicine, Medical Toxicology, and Addiction Medicine. Dr. Lynch graduated from the University of Notre Dame and University of Pittsburgh School of Medicine before completing his residency in Emergency Medicine and fellowship in Medical Toxicology at the University of Pittsburgh. Dr. Lynch works in the Emergency Departments at UPMC Presbyterian and Mercy Hospitals. The Toxicology service at UPMC is one of the busiest in the country, seeing patients at 5 Pittsburgh hospitals as well as providing inpatient addiction and telemedicine treatment. Dr. Lynch is the Medical Director of the Pittsburgh Poison Center and of Substance Use Disorder Services at UPMC Health Plan while continuing to serve on the Boards of Directors for the PA College of Emergency Physicians and the American Association of Poison Control Centers. He has implemented naloxone distribution, emergency department buprenorphine induction, as well as inpatient buprenorphine and methadone initiation and maintenance pathways within the UPMC system. Dr. Lynch began the inpatient addiction medicine consultation service at UPMC with a multidisciplinary team, a poison center based withdrawal and addiction treatment support hotline, and, most recently, implemented a telemedicine addiction bridge clinic serving the entire Commonwealth of Pennsylvania. He served on the Pain Management Best Practices Inter-Agency Task Force at the Department of Health and Human Services.
Dr. Jeanmarie Perrone, MD
Professor of Emergency Medicine and Medical Toxicology, Perelman School of Medicine at the University of Pennsylvania
Jeanmarie Perrone, MD is a Professor in the Department of Emergency Medicine, the Director of the Division of Medical Toxicology and the founding Director of the Center for Addiction Medicine and Policy at the University of Pennsylvania. Dr. Perrone has led numerous investigations and initiatives in opioid stewardship and ED treatment of Opioid Use Disorder (OUD) with buprenorphine. She serves on several regional and national task forces and advisory committees with the State of Pennsylvania, the CDC and FDA addressing judicious opioid use and MOUD treatment access. She has advocated at the state and national level for harm reduction and ED treatment for OUD and is a co-investigator in a 30 site NIDA sponsored trial of ED buprenorphine. Dr. Perrone has been featured in prominent news media including the New York Times, USA Today and National Public Radio and published in the New England Journal of Medicine and JAMA . She has won numerous awards for education and mentorship of students, residents and fellows and is boarded in emergency medicine, medical toxicology and addiction medicine.
No Relevant Financial Disclosures.
Accreditation & Credits
Joint Accreditation Statement
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
- Physicians: 1 Credit
- Nurses & NPs: 1 Nursing Contact Hour
- Pharmacology Hour: 1 Hour
- PAs: 1 Credit
- Pharmacists: 1 Credit
- Social Workers: 1 Credit
- Interprofessional Continuing Education: 1 Credit
- Certified Counselors: NBCC Contact Hours Not offered
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
- NAADAC: No CE Credit
Maintenance of Certification (MOC/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC and CCP Credit are only reported and designated for ABA, ABIM, ABP, ABPM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
- ABPM CCP: 1 Accredited CME | 1 Patient Safety
- ABIM MOC Points: 1 Medical Knowledge | 1 Patient Safety
- ABP MOC: 1 Lifelong Learning & Self-Assessment
- ABS Continuing Certification: 1 Accredited CME | 1 Self-Assessment
- ABA MOCA 2.0®*: 1 Lifelong Learning | 1 Patient Safety MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
- ABA MOCA 2.0®*: 1 Lifelong Learning MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the patient safety CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
- American Board of Psychiatry and Neurology (ABPN)
- Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education. Speaker disclosures are listed on the speakers tab.
See the attached pdf for a list of disclosures.
Key:
Complete
Next
Failed
Available
Locked